Literature DB >> 807579

Biosynthesis of heparin. Studies on the microsomal sulfation process.

M Höök, U Lindahl, A Hallén, G Bäckström.   

Abstract

Nonsulfated, partially N-deacetylated, 14C-labeled polysaccharide was formed by incubation of a mouse mastocytoma microsomal fraction with UDP-[14C]glucuronic acid and UDP-N-acetylglucosamine. After 60 min at 37 degrees the incorporation of radioactivity was interrupted, and sulfation was initiated, by the addition of unlabeled UDP-glucuronic acid and 3-phosphoadenylylsulfate, respectively. After varying periods of incubation with the nucleotide sulfate, polysaccharide was isolated and analyzed by chromatography on DEAE-cellulose. During incubation with 3-phosphoadenylylsulfate, sulfated 14C-polysaccharides were formed, while the nonsulfated 14C-polysaccharide was eliminated, each type of component retaining the same elution position throughout the entire sulfation period (60 min). No accumulation of low sulfated material was observed. Fully sulfated heparin was detected after only 0.5 min of sulfation. These results suggest that the sulfation of heparin is a rapid process, involving a limited number of polysaccharide molecules at a time. Besides heparin-like products, having both N- and O-sulfate groups, and [14C]iduronic acid as predominant uronic acid constituent, an additional sulfated component was detected, having N-sulfate but no O-sulfate groups. This novel polysaccharide contained [14C]glucuronic acid but little or no [14C]iduronic acid. Previous studies have shown that L-iduronic acid residues in heparin are formed by C-5 inversion of D-glucuronic acid units, previously incorporated into the polymer; the inversion reaction requires concomitant sulfation of the polymer. The present results demonstrate that the formation of iduronic acid residues is related to the sulfation of hydroxyl groups. Pulse-chase experiments with 3-phosphoadenylyl[35S]sulfate indicated that the N-sulfated polymer, lacking O-sulfate groups, could be converted into heparin-like products by further sulfation of hydroxyl groups only. The biosynthesis of heparin may thus involve a pathway, in which the formation of N-sulfated intermediates precedes the introduction of O-sulfate groups.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 807579

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  Enzyme interactions in heparan sulfate biosynthesis: uronosyl 5-epimerase and 2-O-sulfotransferase interact in vivo.

Authors:  M A Pinhal; B Smith; S Olson; J Aikawa; K Kimata; J D Esko
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-30       Impact factor: 11.205

2.  Heparin binds to Leishmania donovani promastigotes and inhibits protein phosphorylation.

Authors:  N K Mukhopadhyay; K Shome; A K Saha; J R Hassell; R H Glew
Journal:  Biochem J       Date:  1989-12-01       Impact factor: 3.857

3.  An histochemical approach to characterization of anionic constituents in mast cell secretory granules.

Authors:  E Skutelsky; T Shoichetman; I Hammel
Journal:  Histochem Cell Biol       Date:  1995-12       Impact factor: 4.304

4.  Biosynthesis of heparin. Relationship between the polymerization and sulphation processes.

Authors:  K Lidholt; L Kjellén; U Lindahl
Journal:  Biochem J       Date:  1989-08-01       Impact factor: 3.857

Review 5.  Mechanism of the anticoagulant action of heparin.

Authors:  I Björk; U Lindahl
Journal:  Mol Cell Biochem       Date:  1982-10-29       Impact factor: 3.396

6.  Human glucosamine-6-sulphatase deficiency. Diagnostic enzymology towards heparin-derived trisaccharide substrates.

Authors:  C Freeman; J J Hopwood
Journal:  Biochem J       Date:  1992-03-01       Impact factor: 3.857

7.  Metabolism of macromolecular heparin in mouse neoplastic mast cells.

Authors:  S Ogren; U Lindahl
Journal:  Biochem J       Date:  1976-03-15       Impact factor: 3.857

8.  Biosynthesis of heparin. Use of Escherichia coli K5 capsular polysaccharide as a model substrate in enzymic polymer-modification reactions.

Authors:  M Kusche; H H Hannesson; U Lindahl
Journal:  Biochem J       Date:  1991-04-01       Impact factor: 3.857

Review 9.  Heparan sulfate biosynthesis: regulation and variability.

Authors:  Johan Kreuger; Lena Kjellén
Journal:  J Histochem Cytochem       Date:  2012-10-04       Impact factor: 2.479

10.  Biosynthesis of heparin. Modulation of polysaccharide chain length in a cell-free system.

Authors:  K Lidholt; J Riesenfeld; K G Jacobsson; D S Feingold; U Lindahl
Journal:  Biochem J       Date:  1988-09-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.